Výsledky vyhledávání

Akademický článek

Effectiveness and safety profile of tofacitinib and baricitinib in rheumatoid arthritis patients: results from a 24-month real-life prospective study in Southern-Italy

Autor: M. Tasso, N. Bertolini, E. Mostacciuolo, S. Passavanti, J.M.E. Luppino, A. Del Puente, R. Peluso, F. Santelli, R. Scarpa, L. Costa, F. Caso

Publikováno v: Reumatismo, Vol 74, Iss 3 (2022)

The primary objectives of the study were to evaluate the efficacy and safety of tofacitinib and baricitinib up to 24 months of follow-up in patients with rheumatoid arthritis (RA) treated in Southern Italy. Patients’ data, activity index, and clini

Externí odkaz: https://doaj.org/article/36c0e1477318460fb40c0fe3656af5f6

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Regulatory Volume Increase and Regulatory Volume Decrease Responses in HL-1 Atrial Myocytes

Autor: Veronica I. Cacace, Andres G. Finkelsteyn, Laura M. Tasso, Carlos F. Kusnier, Karina A. Gomez, Jorge Fischbarg

Publikováno v: Cellular Physiology and Biochemistry, Vol 33, Iss 6, Pp 1745-1757 (2014)

Background/Aims: we have investigated whether cultured cardiomyocytes of the cell line HL-1 have the ability to perform regulatory volume responses both in hypotonic and hypertonic conditions. Furthermore, we characterized those regulatory responses

Externí odkaz: https://doaj.org/article/4574f3469ecc467686fa9ba2514f1b48

Zobrazit plný text záznamu

Akademický článek

Galectin-1 Prevents Infection and Damage Induced by Trypanosoma cruzi on Cardiac Cells.

Autor: Alejandro F Benatar, Gabriela A García, Jacqeline Bua, Juan P Cerliani, Miriam Postan, Laura M Tasso, Jorge Scaglione, Juan C Stupirski, Marta A Toscano, Gabriel A Rabinovich, Karina A Gómez

Publikováno v: PLoS Neglected Tropical Diseases, Vol 9, Iss 10, p e0004148 (2015)

BACKGROUND:Chronic Chagas cardiomyopathy caused by Trypanosoma cruzi is the result of a pathologic process starting during the acute phase of parasite infection. Among different factors, the specific recognition of glycan structures by glycan-binding

Externí odkaz: https://doaj.org/article/c1ea2f9a89df432581cca366ca08140c

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Cytokine production but lack of proliferation in peripheral blood mononuclear cells from chronic Chagas' disease cardiomyopathy patients in response to T. cruzi ribosomal P proteins.

Autor: Silvia A Longhi, Augusto Atienza, Graciela Perez Prados, Alcinette Buying, Virginia Balouz, Carlos A Buscaglia, Radleigh Santos, Laura M Tasso, Ricardo Bonato, Pablo Chiale, Clemencia Pinilla, Valeria A Judkowski, Karina A Gómez

Publikováno v: PLoS Neglected Tropical Diseases, Vol 8, Iss 6, p e2906 (2014)

BACKGROUND: Trypanosoma cruzi ribosomal P proteins, P2β and P0, induce high levels of antibodies in patients with chronic Chagas' disease Cardiomyopathy (CCC). It is well known that these antibodies alter the beating rate of cardiomyocytes and provo

Externí odkaz: https://doaj.org/article/0bd950e47e9c46fe8bf624c9f409d641

Zobrazit plný text záznamu

POS1267 LONG-TERM SURVEY STUDY OF THE IMPACT OF COVID-19 ON SYSTEMIC AUTOIMMUNE DISEASES. LOW DEATH RATE DESPITE THE INCREASED PREVALENCE OF SYMPTOMATIC INFECTION. ROLE OF PRE-EXISTING INTERSTITIAL LUNG DISEASE AND ONGOING TREATMENTS

Autor: C. Ferri, V. Raimondo, L. Gragnani, D. Giuggioli, L. Dagna, A. Tavoni, F. Ursini, M. L’andolina, F. Caso, P. Ruscitti, M. Caminiti, R. Foti, V. Riccieri, S. Guiducci, R. Pellegrini, E. Zanatta, G. Varcasia, D. Olivo, P. Gigliotti, G. Cuomo, G. Murdaca, R. Cecchetti, R. De Angelis, N. Romeo, F. Ingegnoli, F. Cozzi, V. Codullo, I. Cavazzana, M. Colaci, G. Abignano, M. De Santis, E. Lubrano, E. Fusaro, A. Spinella, F. Lumetti, G. De Luca, S. Bellando Randone, E. Visalli, Y. Dal Bosco, G. Amato, D. Giannini, S. Bilia, F. Masini, G. Pellegrino, E. Pigatto, E. Generali, G. Pagano Mariano, G. Pettiti, G. Zanframundo, R. Brittelli, V. Aiello, R. Caminiti, D. Scorpiniti, T. Ferrari, C. Campochiaro, V. Brusi, M. Fredi, L. Moschetti, F. Cacciapaglia, S. M. Ferrari, I. DI Cola, M. Vadacca, S. Lorusso, M. Monti, S. Lorini, S. R. Paparo, F. Ragusa, G. Elia, V. Mazzi, M. L. Aprile, M. Tasso, M. Miccoli, S. L. Bosello, S. D’angelo, A. Doria, F. Franceschini, R. Meliconi, M. Matucci-Cerinic, F. Iannone, R. Giacomelli, C. Salvarani, A. L. Zignego, P. Fallahi, A. Antonelli

Publikováno v: Annals of the Rheumatic Diseases. 81:970.2-971

BackgroundPatients with autoimmune systemic diseases (ASDs) can be counted among frail populations as regards the predisposition to COVID-19 due to the frequent visceral organ involvement and comorbidities, as well as the ongoing immunomodulating tre

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::90a1cedb857e19b11f7ac5dec491e2c7
https://doi.org/10.1136/annrheumdis-2022-eular.4522

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání